Feb. 26 (UPI) -- Eli Lilly announced plans for four new pharmaceutical manufacturing sites to produce domestic medicine production in the United States and make the nation the world's leader in pharmaceutical production. The pharmaceutical firm would invest $27 billion to build the four new manufacturing plants in locations that are yet to be determined. Advertisement Eli Lilly chairman and Chief Executive Officer David Ricks in a news release on Wednesday said the new U.S. manufacturing sites